QCM
RXRX icon

Quantinno Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Quantinno Capital Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.7K Sell
10,328
-43,871
-81% -$170K ﹤0.01% 3291
2025
Q4 		$222K Buy
54,199
+24,460
+82% +$121K ﹤0.01% 3012
2025
Q3 		$145K Buy
+29,739
New +$156K ﹤0.01% 2837
2025
Q2 		– Sell
-19,296
Closed -$102K – 2622
2025
Q1 		$102K Buy
+19,296
New +$141K ﹤0.01% 2029

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quantinno Capital Management's RXRX Position: Q1 2026 in Review

Quantinno Capital Management reduced its Recursion Pharmaceuticals (RXRX) stake by 81% in Q1 2026, selling an estimated $170K and leaving 10,328 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3291.

Quantinno Capital Management first reported a position in RXRX in Q1 2025 and has held it in 4 quarters since. The position peaked at $222K in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Quantinno Capital Management held 10,328 shares of Recursion Pharmaceuticals worth $31.7K as of Q1 2026.
  • Quantinno Capital Management sold 43,871 Recursion Pharmaceuticals shares in Q1 2026, an estimated $170K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3291 holding.
  • Quantinno Capital Management first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Recursion Pharmaceuticals position peaked at $222K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.